{
    "organizations": [],
    "uuid": "5a71b67dd739501bd25347c83b47d7360c4b3cf0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-anges-submits-application-for-mark/brief-anges-submits-application-for-marketing-approval-for-hgf-gene-therapy-idUSL4N1PH1LH",
    "ord_in_thread": 0,
    "title": "BRIEF-AnGes submits application for marketing approval for HGF gene therapy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 22 (Reuters) - AnGes Inc :\n* Says it submits application for marketing approval to Pharmaceuticals and Medical Devices Agency (PMDA) for HGF gene therapy for the treatment of critical limb ischemia (CLI)\nSource text in Japanese: goo.gl/DKLSkV\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-22T10:50:00.000+02:00",
    "crawled": "2018-01-22T20:42:35.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "anges",
        "inc",
        "say",
        "submits",
        "application",
        "marketing",
        "approval",
        "pharmaceutical",
        "medical",
        "device",
        "agency",
        "pmda",
        "hgf",
        "gene",
        "therapy",
        "treatment",
        "critical",
        "limb",
        "ischemia",
        "cli",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}